Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Clinical trial NCT00503204 · COMPLETED

Trial details

NCT number: NCT00503204
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma Brain Tumor

Start date: 2007-09-01
Primary completion: 2008-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.